U.S., U.K. Reach Agreement in Principle on Pharmaceutical Pricing

Posted 12/1/25

The United States and the United Kingdom announced an agreement in principle to realign pharmaceutical pricing and reinforce bilateral life-sciences investment, a central pillar of the new U.S.–U.K. Economic Prosperity Deal (EPD).

This item is available in full to subscribers.

Please log in to continue

Log in